Sandu Pharmaceuticals Ltd Q3 FY2023-2024 Results: Summary
Revenue | ₹17.46Cr |
Net Profits | ₹0.21Cr |
Net Profit Margins | 1.20% |
Highlights
Revenue:
Sandu Pharmaceuticals Ltd’s revenue jumped 1.99% since last year same period to ₹17.46Cr in the Q3 2023-2024. On a quarterly growth basis, Sandu Pharmaceuticals Ltd has generated 4.61% jump in its revenue since last 3-months.
Net Profits:
Sandu Pharmaceuticals Ltd’s net profit fell -56.25% since last year same period to ₹0.21Cr in the Q3 2023-2024. On a quarterly growth basis, Sandu Pharmaceuticals Ltd has generated -61.82% fall in its net profits since last 3-months.
Net Profit Margins:
Sandu Pharmaceuticals Ltd’s net profit margin fell -57.1% since last year same period to 1.20% in the Q3 2023-2024. On a quarterly growth basis, Sandu Pharmaceuticals Ltd has generated -63.5% fall in its net profit margins since last 3-months.
